All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Potential for Treatment of Neurodegenerative Diseases with Natural Products or Synthetic Compounds that Stabilize Microtubules

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F20%3A73606471" target="_blank" >RIV/61989592:15110/20:73606471 - isvavai.cz</a>

  • Result on the web

    <a href="https://www.eurekaselect.com/182999/article" target="_blank" >https://www.eurekaselect.com/182999/article</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.2174/1381612826666200621171302" target="_blank" >10.2174/1381612826666200621171302</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Potential for Treatment of Neurodegenerative Diseases with Natural Products or Synthetic Compounds that Stabilize Microtubules

  • Original language description

    No effective therapeutics to treat neurodegenerative diseases exist, despite significant attempts to find drugs that can reduce or rescue the debilitating symptoms of tauopathies such as Alzheimer&apos;s disease, Parkinson&apos;s disease, frontotemporal dementia, amyotrophic lateral sclerosis, or Pick&apos;s disease. A number of in vitro and in vivo models exist for studying neurodegenerative diseases, including cell models employing induced-pluripotent stem cells, cerebral organoids, and animal models of disease. Recent research has focused on microtubulestabilizing agents, either natural products or synthetic compounds that can prevent the axonal destruction caused by tau protein pathologies. Although promising results have come from animal model studies using brainpenetrant natural product microtubule-stabilizing agents, such as paclitaxel analogs that can access the brain, epothilones B and D, and other synthetic compounds such as davunetide or the triazolopyrimidines, early clinical trials in humans have been disappointing. This review aims to summarize the research that has been carried out in this area and discuss the potential for the future development of an effective microtubule stabilizing drug to treat neurodegenerative disease.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database

  • CEP classification

  • OECD FORD branch

    10608 - Biochemistry and molecular biology

Result continuities

  • Project

    <a href="/en/project/EF16_019%2F0000868" target="_blank" >EF16_019/0000868: Molecular, cellular and clinical approach to healthy ageing</a><br>

  • Continuities

Others

  • Publication year

    2020

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    CURRENT PHARMACEUTICAL DESIGN

  • ISSN

    1381-6128

  • e-ISSN

  • Volume of the periodical

    26

  • Issue of the periodical within the volume

    35

  • Country of publishing house

    AE - UNITED ARAB EMIRATES

  • Number of pages

    11

  • Pages from-to

    4362-4372

  • UT code for WoS article

    000582502300003

  • EID of the result in the Scopus database

    2-s2.0-85090789780